Development and validation of the radiomics nomogram
RS
DISEASE PROGRESSION
A nomogram of the RS, CA19-9 and chemotherapy was constructed (Fig. 
Developed the radiomics nomogram to predict the risk of disease progression after treatment with chemotherapy in a given patient (The decision curve analysis (DCA) and clinical impact curve of the nomogram are shown in Fig. 
Decision curve analysis for the radiomics nomogram (